130 Participants Needed

Combined LMA + ETT Technique for Emergence Phenomena

(LEPAGA Trial)

JP
DM
CR
AB
Overseen ByArne Budde, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Milton S. Hershey Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new method to help people wake up more comfortably after surgery. Researchers compare two anesthesia techniques: one using an endotracheal tube (ETT) and another combining an ETT with a laryngeal mask airway (LMA). The goal is to determine if this combined method can reduce issues like coughing or restlessness upon waking. It suits those undergoing elective laparoscopic surgery without a high risk of stomach acid reflux. As an unphased trial, this study allows participants to contribute to innovative research that could enhance post-surgical recovery experiences.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this airway management technique is safe?

Research shows that using an Ambu AuraGain laryngeal mask airway (LMA) with an endotracheal tube (ETT) is generally safe for assisting adult breathing during surgery. This method can reduce issues like coughing, straining, and restlessness upon waking from anesthesia, which can otherwise cause high blood pressure and a rapid heartbeat.

Other studies using similar device combinations have also proven safe and helped maintain stable heart rate and blood pressure during surgery. This suggests that patients generally tolerate this combined approach well. However, since this trial specifically examines this combination further, participants should know it might not provide complete information on long-term safety. Still, current research offers a reassuring view of the treatment's safety in humans.12345

Why are researchers excited about this trial?

Researchers are excited about the combined LMA and ETT technique for managing emergence phenomena because it offers a novel approach to airway management. Unlike the traditional method of endotracheal tube (ETT) intubation, this technique involves placing a laryngeal mask airway (LMA) first, followed by ETT intubation through the LMA with a fiberoptic bronchoscope. This method aims to reduce airway trauma and improve patient comfort during anesthesia emergence by allowing the ETT to be removed while the patient is still deeply anesthetized, with ventilation continuing via the LMA until full emergence. This innovative approach could lead to smoother recoveries and fewer complications compared to standard ETT-only procedures.

What evidence suggests that this trial's airway management techniques could be effective for reducing emergence phenomena?

Research has shown that using a laryngeal mask airway (LMA) during recovery from general anesthesia can reduce issues such as coughing, restlessness, and high blood pressure. This trial will compare two approaches: one group will use only an endotracheal tube (ETT), while another group will use a combined LMA and ETT technique. The combined technique aims to offer the benefits of both methods, maintaining a secure airway like the ETT during surgery while reducing waking-up issues like the LMA. Studies suggest this combination can lead to more stable conditions as patients wake up. This approach may be particularly beneficial in surgeries requiring higher breathing support or for patients at risk of stomach acid reflux.12456

Who Is on the Research Team?

AB

Arne Budde, MD

Principal Investigator

Penn State M.S. Hershey Medical Center

Are You a Good Fit for This Trial?

This trial is for adults with an ASA classification of 1-3 who are having elective laparoscopic surgery. It's not for those unable to consent, needing translators for consent, prisoners, pregnant women, non-fasted patients or at high risk of gastric reflux and aspiration.

Inclusion Criteria

I am scheduled for elective laparoscopic surgery.
My health is good to moderately impaired.

Exclusion Criteria

Parturients
Non-fasted patients (as per HMC Anesthesiology Department NPO policy)
Individuals who would require translation services to provide consent
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Induction and Airway Management

Induction of anesthesia and initial airway management with LMA, followed by intubation with ETT using a fiberoptic bronchoscope.

Intraoperative

Surgical Procedure

Ventilation with ETT throughout the surgical procedure.

Intraoperative

Emergence

Removal of ETT while deeply anesthetized, followed by ventilation with LMA until emergence.

Intraoperative

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of sore throat and oropharyngeal sensory or motor nerve palsy.

Up to 1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Emergence from anesthesia
  • Induction of anesthesia
  • Intubation of the trachea through the LMA
  • Laryngoscopy and placement of ETT
  • Placement of LMA [Ambu (R) AuraGain (TM) disposable laryngeal mask]
  • Removal of the ETT
  • Ventilation via the ETT
  • Ventilation via the LMA
Trial Overview The study tests a technique combining laryngeal mask airway (LMA) and endotracheal tube (ETT) to see if it can provide a secure airway during surgery while reducing emergence phenomena like coughing and restlessness after anesthesia.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Combined ETT/LMA techniqueExperimental Treatment7 Interventions
Group II: ETT onlyActive Control5 Interventions

Laryngoscopy and placement of ETT is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as Endotracheal Tube for:
🇺🇸
Approved in United States as Endotracheal Tube for:
🇨🇦
Approved in Canada as Endotracheal Tube for:
🇯🇵
Approved in Japan as Endotracheal Tube for:
🇨🇳
Approved in China as Endotracheal Tube for:
🇨🇭
Approved in Switzerland as Endotracheal Tube for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Milton S. Hershey Medical Center

Lead Sponsor

Trials
515
Recruited
2,873,000+

Ambu A/S

Industry Sponsor

Trials
24
Recruited
5,700+

Published Research Related to This Trial

In a study of 116 patients, the Ambu®AuraGain™ laryngeal mask (LM) provided better laryngeal alignment for fibreoptic intubation compared to the LMA® Fastrach™, with 49% of patients achieving a Grade 4 view versus 37% for the Fastrach (P=0.003).
The AuraGain LM also allowed for significantly quicker and easier endotracheal tube (ETT) intubation and was faster to insert than the Fastrach LMA, while both devices had similar rates of minor complications like sore throat.
A randomised controlled trial comparing fibreoptic-guided tracheal intubation through two supraglottic devices: Ambu® AuraGain™ laryngeal mask and LMA® Fastrach™.Preece, G., Ng, I., Lee, K., et al.[2022]
In a study of 484 patients undergoing otologic surgery, the laryngeal mask airway (LMA) was found to be a safe alternative to the oral endotracheal tube (ETT), with no major airway complications reported in either group.
The LMA group required significantly fewer neuromuscular blocking agents and had shorter operating room times compared to the ETT group, indicating potential benefits in efficiency without compromising safety.
Laryngeal mask airway use in otologic surgery.Ayala, MA., Sanderson, A., Marks, R., et al.[2009]
In a study involving eight military medics with limited clinical experience, the Ambu® AuraOnce ™ disposable laryngeal mask (LMA) achieved a 100% success rate for airway management on the first attempt, indicating it is highly effective and requires minimal training for use.
The disposable laryngeal suction tube (LTS-D) had a first-attempt success rate of 73.7% overall, but the LMA significantly reduced the time to verified ventilation, suggesting that the LMA is the preferred airway adjunct for inexperienced providers in emergency situations.
Are the King LTS Laryngeal Tube and the Ambu AuraOnce Laryngeal Mask Useful Airway Adjuncts for Military Medics?Regner, D., Frykholm, P.[2022]

Citations

Limiting Emergence Phenomena After General Anesthesia ...Emergence from general anesthesia with a laryngeal mask airway compared with an endotracheal tube has been shown to favorable with respect to limiting ...
Limiting Emergence Phenomena After General Anesthesia ...Emergence from general anesthesia with a laryngeal mask airway compared with an endotracheal tube has been shown to favorable with respect to ...
Combined LMA + ETT Technique for Emergence ...Research shows that using a laryngeal mask airway (LMA) can be safer and more effective than an endotracheal tube (ETT) in certain surgeries, as it reduces ...
A prospective randomized control study comparing classic ...LMA™ is superior to OPA™ for exchange of ETT as it provides greater hemodynamic stability. Keywords: Airway extubation, airway management, laryngeal mask ...
I-gel Laryngeal Mask Airway Combined with Tracheal ...Utilization of I-gel combined with endotracheal tube in posterior fossa surgery patients is safe which can yield more stable hemodynamic profile ...
Investigation of Endotracheal Tube Versus Laryngeal Mask ...In this study, we aim to elucidate whether a difference in emergence times exists between using an ETT or LMA after general anesthesia.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security